Long-term proton pump inhibitor use does not raise hip fracture risk
Intended for healthcare professionals
Journal scan Previous     Next

Long-term proton pump inhibitor use does not raise hip fracture risk

Ruth Sander Independent consultant, Care of the older person

Proton pump inhibitors (PPIs) reduce the production of stomach acid and are effective drugs for gastro-oesophageal reflux disease that are commonly prescribed to older people.

Nursing Older People. 30, 4, 13-13. doi: 10.7748/nop.30.4.13.s11

Want to read more?

RCNi-Plus
Already have access? Log in

or

3-month trial offer for £5.25/month

Subscribe today and save 50% on your first three months
RCNi Plus users have full access to the following benefits:
  • Unlimited access to all 10 RCNi Journals
  • RCNi Learning featuring over 175 modules to easily earn CPD time
  • NMC-compliant RCNi Revalidation Portfolio to stay on track with your progress
  • Personalised newsletters tailored to your interests
  • A customisable dashboard with over 200 topics
Subscribe

Alternatively, you can purchase access to this article for the next seven days. Buy now


Are you a student? Our student subscription has content especially for you.
Find out more